$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

$zvra Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015705 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$4.449M	$3.425M	$2.879M
YoY Change	-47.47%	18.96%	-27.39%
Cost Of Revenue	$1.546M	$1.528M	$125.0K
YoY Change	128.36%	1122.4%	1462.5%
Gross Profit	$2.903M	$1.897M	$2.754M
YoY Change	-62.75%	-31.12%	-30.4%
Gross Profit Margin	65.25%	55.39%	95.66%
Selling, General & Admin	$12.60M	$9.931M	$6.834M
YoY Change	79.93%	45.32%	149.96%
% of Gross Profit	434.17%	523.51%	248.15%
Research & Development	$10.52M	$12.28M	$8.844M
YoY Change	41.54%	38.82%	186.96%
% of Gross Profit	362.42%	647.18%	321.13%
Depreciation & Amortization	$1.562M	$1.562M	$79.00K
YoY Change	1852.5%	1877.22%	21.54%
% of Gross Profit	53.81%	82.34%	2.87%
Operating Expenses	$23.13M	$22.21M	$15.68M
YoY Change	60.17%	41.65%	408.7%
Operating Profit	-$23.80M	-$20.49M	-$12.92M
YoY Change	258.09%	58.51%	595.21%
Interest Expense	$3.940M	$735.0K	$182.0K
YoY Change	1900.0%	303.85%	3540.0%
% of Operating Profit
Other Income/Expense, Net	$3.940M	$3.794M	$1.054M
YoY Change	164.96%	259.96%	-11811.11%
Pretax Income	-$19.86M	-$16.69M	-$11.87M
YoY Change	284.94%	40.62%	535.44%
Income Tax	$70.00K	-$70.00K	-$103.0K
% Of Pretax Income
Net Earnings	-$19.93M	-$16.62M	-$11.77M
YoY Change	291.92%	41.26%	531.28%
Net Earnings / Revenue	-447.85%	-485.31%	-408.72%
Basic Earnings Per Share	-$0.48	-$0.40	-$0.34
Diluted Earnings Per Share	-$0.48	-$0.40	-$0.34
COMMON SHARES
Basic Shares Outstanding	41.85M	43.43M	34.54M
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$49.26M	$52.72M	$74.58M
YoY Change	-43.31%	-29.32%	-26.58%
Cash & Equivalents	$39.26M	$42.85M	$40.18M
Short-Term Investments	$9.998M	$9.868M	$34.40M
Other Short-Term Assets	$2.686M	$1.868M	$1.200M
YoY Change	34.3%	55.67%	36.36%
Inventory
Prepaid Expenses
Receivables	$8.947M	$8.305M	$7.800M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$60.89M	$62.89M	$104.3M
YoY Change	-41.13%	-39.69%	-1.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$678.0K	$695.0K	$744.0K
YoY Change	-1.6%	-6.59%	-10.9%
Goodwill	$4.700M	$4.700M
YoY Change
Intangibles	$66.15M	$67.70M
YoY Change
Long-Term Investments			$0.00
YoY Change			-100.0%
Other Assets	$875.0K	$1.786M	$53.00K
YoY Change	1550.94%	3269.81%	-87.87%
Total Long-Term Assets	$83.52M	$88.39M	$2.315M
YoY Change	3894.12%	3718.27%	-88.38%
TOTAL ASSETS
Total Short-Term Assets	$60.89M	$62.89M	$104.3M
Total Long-Term Assets	$83.52M	$88.39M	$2.315M
Total Assets	$144.4M	$151.3M	$106.6M
YoY Change	36.86%	41.92%	-15.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.45M	$22.79M	$10.10M
YoY Change	94.78%	125.59%	291.17%
Accrued Expenses	$596.0K	$583.0K	$500.0K
YoY Change	19.2%	16.6%	40.45%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$4.452M	$4.800M
YoY Change	-100.0%	-7.25%	68471.43%
Total Short-Term Liabilities	$30.45M	$29.91M	$15.62M
YoY Change	66.83%	91.53%	430.25%
LONG-TERM LIABILITIES
Long-Term Debt	$58.33M	$37.94M	$12.90M
YoY Change	359.28%	194.1%	322400.0%
Other Long-Term Liabilities	$6.638M	$8.537M	$158.0K
YoY Change	1994.01%	5303.16%	444.83%
Total Long-Term Liabilities	$64.97M	$8.537M	$158.0K
YoY Change	20394.01%	5303.16%	444.83%
TOTAL LIABILITIES
Total Short-Term Liabilities	$30.45M	$29.91M	$15.62M
Total Long-Term Liabilities	$64.97M	$8.537M	$158.0K
Total Liabilities	$111.9M	$102.5M	$35.19M
YoY Change	202.36%	191.17%	736.49%
SHAREHOLDERS EQUITY
Retained Earnings	-$436.3M	-$416.4M	-$320.3M
YoY Change	34.07%	29.99%	19.13%
Common Stock	$479.4M	$476.1M	$402.8M
YoY Change	18.32%	18.19%	1.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$10.98M	$10.98M	$10.98M
YoY Change	0.0%	0.0%	45.74%
Treasury Stock Shares
Shareholders Equity	$32.48M	$48.82M	$71.40M
YoY Change
Total Liabilities & Shareholders Equity	$144.4M	$151.3M	$106.6M
YoY Change	36.86%	41.92%	-15.2%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$19.93M	-$16.62M	-$11.77M
YoY Change	291.92%	41.26%	531.28%
Depreciation, Depletion And Amortization	$1.562M	$1.562M	$79.00K
YoY Change	1852.5%	1877.22%	21.54%
Cash From Operating Activities	-$19.11M	-$16.17M	-$4.045M
YoY Change	119.64%	299.63%	16.07%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$29.00K
YoY Change	-100.0%	-100.0%	81.25%
Acquisitions
YoY Change
Other Investing Activities	-$129.0K	$14.79M	-$17.53M
YoY Change	-100.38%	-184.39%	357.46%
Cash From Investing Activities	-$129.0K	$14.79M	-$17.56M
YoY Change	-100.38%	-184.27%	356.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	15.33M	$1.217M	-$3.750M
YoY Change	1513.68%	-132.45%	-21.89%
NET CHANGE
Cash From Operating Activities	-19.11M	-$16.17M	-$4.045M
Cash From Investing Activities	-129.0K	$14.79M	-$17.56M
Cash From Financing Activities	15.33M	$1.217M	-$3.750M
Net Change In Cash	-3.908M	-$200.0K	-$25.29M
YoY Change	-114.86%	-99.21%	108.38%
FREE CASH FLOW
Cash From Operating Activities	-$19.11M	-$16.17M	-$4.045M
Capital Expenditures	$0.00	$0.00	$29.00K
Free Cash Flow	-$19.11M	-$16.17M	-$4.074M
YoY Change	119.14%	296.78%	16.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43426186
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43110360
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41850494
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41534668
CY2024Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
CY2024Q1	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
CY2023Q4	us-gaap	Goodwill Goodwill	4700000	usd
CY2023Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2000000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P11Y
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	6200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6200000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6200000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-36913
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5894398
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	1180 Celebration Boulevard, Suite 103
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Celebration
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34747
CY2024Q1	dei	City Area Code CityAreaCode	321
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	939-3416
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2024Q1	dei	Trading Symbol TradingSymbol	ZVRA
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41853494
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	42849000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	43049000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	9868000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	24688000	usd
CY2024Q1	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	8305000	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	17377000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1868000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1824000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	62890000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	86938000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	12426000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9841000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	695000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	736000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1086000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	790000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4701000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4701000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	67699000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	69227000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1786000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	94000	usd
CY2024Q1	us-gaap	Assets Assets	151283000	usd
CY2023Q4	us-gaap	Assets Assets	172327000	usd
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	22785000	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	28403000	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	37700000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	583000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	543000	usd
CY2024Q1	zvra	Discount And Rebate Liabilities Current DiscountAndRebateLiabilitiesCurrent	4452000	usd
CY2023Q4	zvra	Discount And Rebate Liabilities Current DiscountAndRebateLiabilitiesCurrent	4550000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2089000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2524000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	29909000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73720000	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	5059000	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	5066000	usd
CY2024Q1	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	37939000	usd
CY2023Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	usd
CY2024Q1	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	11535000	usd
CY2023Q4	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	16100000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	705000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	456000	usd
CY2024Q1	zvra	Discount And Rebate Liabilities Noncurrent DiscountAndRebateLiabilitiesNoncurrent	8781000	usd
CY2023Q4	zvra	Discount And Rebate Liabilities Noncurrent DiscountAndRebateLiabilitiesNoncurrent	7663000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8537000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7458000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	102465000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	110463000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	476056000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	472664000	usd
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	10983000	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10983000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-416400000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399778000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	141000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-43000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	48818000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	61864000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	151283000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	172327000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3425000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3176000	usd
CY2024Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	175000	usd
CY2023Q1	us-gaap	Cost Of Goods And Service Excluding Depreciation Depletion And Amortization CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization	125000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1528000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	0	usd
CY2024Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	12277000	usd
CY2023Q1	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	8655000	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9931000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7227000	usd
CY2024Q1	us-gaap	Costs And Expenses CostsAndExpenses	22208000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	15882000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-20486000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-12831000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	735000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	182000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3627000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1545000	usd
CY2024Q1	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	27000	usd
CY2023Q1	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	-196000	usd
CY2024Q1	zvra	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	929000	usd
CY2023Q1	zvra	Interest And Other Income Expense Net InterestAndOtherIncomeExpenseNet	1042000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3794000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-489000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16692000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13320000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-70000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-103000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-16622000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13217000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41778774
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34466542
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-16622000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13217000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	184000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-176000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	184000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-176000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-16438000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13393000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-16622000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2119000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	56000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	71000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1146000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	184000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	48818000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13217000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	945000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3447000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	42000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-176000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	59267000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-16622000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13217000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2119000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	945000	usd
CY2024Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	239000	usd
CY2023Q1	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1562000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	79000	usd
CY2024Q1	zvra	Fair Value Adjustment Of Warrants And Cvr Liability FairValueAdjustmentOfWarrantsAndCvrLiability	-3627000	usd
CY2023Q1	zvra	Fair Value Adjustment Of Warrants And Cvr Liability FairValueAdjustmentOfWarrantsAndCvrLiability	1545000	usd
CY2024Q1	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	27000	usd
CY2023Q1	zvra	Fair Value Adjustment Of Investments FairValueAdjustmentOfInvestments	-196000	usd
CY2024Q1	zvra	Consulting Fees Paid In Stock ConsultingFeesPaidInStock	56000	usd
CY2023Q1	zvra	Consulting Fees Paid In Stock ConsultingFeesPaidInStock	42000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-229000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	240000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-9072000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-477000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	44000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-703000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2585000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-51000	usd
CY2024Q1	zvra	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-123000	usd
CY2023Q1	zvra	Increase Decrease In Operating Lease Rightofuse Asset IncreaseDecreaseInOperatingLeaseRightofuseAsset	-80000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7306000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3836000	usd
CY2024Q1	zvra	Increase Decrease In Discount And Rebate Liabilities IncreaseDecreaseInDiscountAndRebateLiabilities	1020000	usd
CY2023Q1	zvra	Increase Decrease In Discount And Rebate Liabilities IncreaseDecreaseInDiscountAndRebateLiabilities	1528000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-130000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-107000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-298000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	429000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-16165000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4045000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	-0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29000	usd
CY2024Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-14793000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	17526000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14793000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-17555000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	12914000	usd
CY2024Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	-0	usd
CY2023Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	12800000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	-0	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3447000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1217000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024Q1	zvra	Payments Of Principal On Insurance Financing Arrangements PaymentsOfPrincipalOnInsuranceFinancingArrangements	-0	usd
CY2023Q1	zvra	Payments Of Principal On Insurance Financing Arrangements PaymentsOfPrincipalOnInsuranceFinancingArrangements	415000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	-0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1217000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3750000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-45000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-200000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-25285000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43049000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	65466000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	42849000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	40181000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	140000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	68000	usd
CY2024Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	1726000	usd
CY2023Q1	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-16600000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13200000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-416400000	usd
CY2024Q1	zvra	Common Stock Registered Shares CommonStockRegisteredShares	2269721
CY2021Q3	zvra	Sale Of Stock Authorized Amount SaleOfStockAuthorizedAmount	350000000	usd
CY2021Q4	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><i><b>Use of Estimates</b></i></p> <p style="margin: 0pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition, the useful lives of property and equipment, the recoverability of long-lived assets, the incremental borrowing rate for leases, and assumptions used for purposes of determining stock-based compensation, income taxes, the fair value of investments and the fair value of the derivative and warrant liability and discount and rebate liabilities, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p>
CY2024Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	9900000	usd
CY2023Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	24700000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-100000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	200000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4044000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2938000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3309000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1884000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5073000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5019000	usd
CY2024Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	12426000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	9841000	usd
CY2024Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	100000	usd
CY2023Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	0	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43426186
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	43110360
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41850494
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41534668
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	20634845
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	16695928
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41534668
CY2024Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	9000
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	306826
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41850494
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5603729
CY2023Q4	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	1382489
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	11500000	usd
CY2023Q4	zvra	Derivative And Warrant Liability Noncurrent DerivativeAndWarrantLiabilityNoncurrent	16100000	usd
CY2024Q1	zvra	Fair Value Adjustment Of Put Option Net Of Tax FairValueAdjustmentOfPutOptionNetOfTax	4600000	usd
CY2023Q1	zvra	Fair Value Adjustment Of Put Option Net Of Tax FairValueAdjustmentOfPutOptionNetOfTax	1500000	usd
CY2021Q2	zvra	Employee Stock Purchase Plan Maximum Number Of Issuable Shares EmployeeStockPurchasePlanMaximumNumberOfIssuableShares	1500000
	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	159828
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2119000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	591000	usd
CY2024Q1	zvra	Class Of Warrant Or Right Liability Weighted Average Fair Value ClassOfWarrantOrRightLiabilityWeightedAverageFairValue	2.17
CY2023	zvra	Class Of Warrant Or Right Liability Weighted Average Fair Value ClassOfWarrantOrRightLiabilityWeightedAverageFairValue	2.94
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	55000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	13000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	13000	usd
CY2024Q1	us-gaap	Sublease Income SubleaseIncome	39000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	16100000	usd
CY2024Q1	zvra	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment	-4565000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	11535000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	9970266
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10277379
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-16622000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-13217000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41779000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34467000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.4
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2024Q1	zvra	Lessee Lease Option To Extend Maximum Term LesseeLeaseOptionToExtendMaximumTerm	P5Y
CY2024Q1	zvra	Lessee Lease Option To Terminate Term LesseeLeaseOptionToTerminateTerm	P1Y
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	32000	usd
CY2024Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2023Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	usd
CY2024Q1	zvra	Finance Lease Cost Total FinanceLeaseCostTotal	12000	usd
CY2023Q1	zvra	Finance Lease Cost Total FinanceLeaseCostTotal	32000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	93000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	113000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	59000	usd
CY2023Q1	us-gaap	Sublease Income SubleaseIncome	39000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	138000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	174000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	123000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	142000	usd
CY2024Q1	us-gaap	Short Term Lease Payments ShortTermLeasePayments	59000	usd
CY2023Q1	us-gaap	Short Term Lease Payments ShortTermLeasePayments	55000	usd
CY2024Q1	us-gaap	Variable Lease Payment VariableLeasePayment	13000	usd
CY2023Q1	us-gaap	Variable Lease Payment VariableLeasePayment	13000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	419000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	137000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	149000	usd
CY2024Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	0	usd
CY2024Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1086000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	790000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1086000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	790000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	583000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	543000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	705000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	456000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1288000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	999000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2024Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P14Y3M18D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.093	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.076	pure
CY2024Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	531000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	511000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	142000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	132000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	155000	usd
CY2024Q1	zvra	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2024Q1	zvra	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	40000	usd
CY2024Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1511000	usd
CY2024Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	-0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	223000	usd
CY2024Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1288000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	575000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets	278000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	11000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	9376000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	35000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets	209000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Approved Product Olpruva BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedApprovedProductOlpruva	68000000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	2000000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	85185000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses	10881000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Collaboration Funding BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredCollaborationFunding	1500000	usd
CY2023Q4	zvra	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities	175000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	12556000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	72629000	usd
CY2024Q1	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	3176000	usd
CY2024Q1	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-20652000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	4700000	usd
CY2024Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2000000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1500000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	6200000	usd

Files In Submission

Name	View Source	Status
0001437749-24-015705-index-headers.html	Edgar Link	pending
0001437749-24-015705-index.html	Edgar Link	pending
0001437749-24-015705.txt	Edgar Link	pending
0001437749-24-015705-xbrl.zip	Edgar Link	pending
ex_649814.htm	Edgar Link	pending
ex_649815.htm	Edgar Link	pending
ex_649816.htm	Edgar Link	pending
ex_649817.htm	Edgar Link	pending
ex_670175.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zvra-20240331.xsd	Edgar Link	pending
zvra20240331_10q.htm	Edgar Link	pending
zvra20240331_10q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
zvra-20240331_lab.xml	Edgar Link	unprocessable
zvra-20240331_cal.xml	Edgar Link	unprocessable
zvra-20240331_def.xml	Edgar Link	unprocessable
zvra-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra

2024 Q2 Form 10-Q Financial Statement

#000143774924015705 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA ZEVRA THERAPEUTICS, INC. Stock $zvra

2024 Q2 Form 10-Q Financial Statement

#000143774924015705 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ZVRA
ZEVRA THERAPEUTICS, INC. Stock $zvra